- View All Peptides
- - View All Peptides
Bronchogen 20mg
Original price was: $34.99.$29.99Current price is: $29.99.Key Research Areas
Research involving Bronchogen 20mg includes:
Exploring reduction of inflammation in lung tissue in preclinical models
Investigating support for epithelial cell health
Assessing potential benefits for overall lung tissue function
Important Notice:
Bronchogen 20mg is intended for research use only. It is not for human or veterinary use, consumption, or administration. This product is not approved by any regulatory agency for clinical or therapeutic purposes. - - View All Peptides
Cagrilitinide 10mg
Original price was: $109.99.$89.99Current price is: $89.99.Key Research Areas
- Peptides
Cagrilitinide 5mg
Original price was: $59.99.$49.99Current price is: $49.99.Key Research Areas
- - View All Peptides
Cardiogen 20mg
Original price was: $34.99.$29.99Current price is: $29.99.Key Research Areas
Research involving Cardiogen 20mg includes:
Supporting cardiovascular tissue health in preclinical models
Enhancing vascular function in laboratory studies
Exploring mechanisms of cardiovascular repair and regeneration
Important Notice:
Cardiogen 20mg is for research use only. It is not intended for human or veterinary use, consumption, or administration. This product is not approved by regulatory authorities for clinical or therapeutic use. - - View All Peptides
Cartalax 20mg
Original price was: $34.99.$24.99Current price is: $24.99.Key Research Areas
Research involving Cartalax 20mg includes:
Promoting cartilage repair in preclinical models
Enhancing joint function in laboratory settings
Investigating anti-inflammatory effects related to joint health
Important Notice:
Cartalax 20mg is for research use only. It is not approved for human or veterinary use, consumption, or administration. This product is not intended for sale or distribution as a therapeutic or diagnostic agent. - - View All Peptides
Cerebrolysin 60mg
Original price was: $39.99.$29.99Current price is: $29.99.Key Research Areas (Preclinical Models Only)
Cerebrolysin has been evaluated in various animal and cell-based models for its potential effects in the following research domains:
Neuroprotection: Studied for its ability to reduce excitotoxicity and oxidative stress in neuronal cells.
Cognitive Function: Explored in behavioral and biochemical assays for potential impact on memory and learning.
Neuroplasticity and Synaptogenesis: Examined for effects on synaptic density and dendritic spine formation in injury and aging models.
Ischemic Brain Injury Recovery: Investigated for its possible support in recovery following induced stroke or traumatic brain injury.
Neurodegeneration Models: Used in research simulating conditions such as Alzheimer’s, Parkinson’s, and other neurodegenerative pathologies.
- - View All Peptides
Chonluten 20mg
Original price was: $39.99.$24.99Current price is: $24.99.Key Research Area
Chonluten is a synthetic tripeptide composed of Glu-Asp-Gly. It is designed to investigate its potential benefits in supporting cartilage and connective tissue health. Research suggests it may promote tissue repair and support joint function.
Research Use Only:
Chonluten 20mg is intended strictly for in vitro testing and laboratory experimentation. It is not intended for human or animal medical use. It is not a drug, food, or cosmetic and should not be misbranded, misused, or mislabeled as such.
- - View All Peptides
CJC-1295 + Ipamorelin 5mg/5mg
Original price was: $34.99.$29.99Current price is: $29.99.Key Research Areas
Current preclinical and laboratory research into this combination includes:
Endocrine Modulation Studies: Investigating pulsatile release of growth hormone in animal models and cellular assays.
Muscle Tissue Analysis: Studying pathways related to protein synthesis and tissue regeneration under controlled research conditions.
Adipose Tissue Research: Exploring possible signaling changes in lipid metabolism models.
Recovery Models: Evaluating biochemical markers associated with tissue remodeling and repair.
Hypothalamic-Pituitary Axis Studies: Used to study the regulatory effects of GHRH and GHS analogs on hormonal feedback loops.
Research Use Only Disclaimer:
This product is intended for laboratory research use only. It is not approved by the FDA for human consumption, medical, veterinary, or diagnostic use. Any use beyond controlled scientific research is strictly prohibited. - - View All Peptides
CJC-1295 No DAC 10mg
Original price was: $59.99.$44.99Current price is: $44.99.Key Research Areas
In research environments, CJC-1295 with DAC has been studied for its potential roles in:
Supporting investigations into GH/IGF-1 axis modulation
Evaluating models of metabolic efficiency and body composition
Examining age-related changes in hormone secretion
Analyzing tissue regeneration and protein synthesis pathways
Understanding the impact of prolonged GHRH analogs on physiological systems
While early findings from controlled studies may suggest possible effects on muscle recovery, fat metabolism, and other outcomes, CJC-1295 with DAC is not authorized for use in humans or animals outside of research settings. It remains an investigational peptide.
Research Use Only:
The peptide is intended strictly for in vitro testing and laboratory experimentation. It’s not intended for human or animal medical use. It’s not a drug, food, or cosmetic and should not be misbranded, misused, or mislabeled as such.
- - View All Peptides
CJC-1295 No DAC 5mg
Original price was: $29.99.$24.99Current price is: $24.99.Key Research Areas
Research into CJC-1295 No DAC focuses on its effects in:
Enhancing lean muscle mass and recovery
Promoting fat loss through increased lipolysis
Supporting metabolic and anabolic functions
Investigating anti-aging effects related to GH modulation
Important Notice
This compound is intended strictly for laboratory research use only. It is not approved for human use, administration, or consumption. Proper handling and safety protocols should be followed.
- - View All Peptides
CJC-1295 with DAC 2mg
Original price was: $29.99.$19.99Current price is: $19.99.Key Research Areas
In research environments, CJC-1295 with DAC has been studied for its potential roles in:
Supporting investigations into GH/IGF-1 axis modulation
Evaluating models of metabolic efficiency and body composition
Examining age-related changes in hormone secretion
Analyzing tissue regeneration and protein synthesis pathways
Understanding the impact of prolonged GHRH analogs on physiological systems
While early findings from controlled studies may suggest possible effects on muscle recovery, fat metabolism, and other outcomes, CJC-1295 with DAC is not authorized for use in humans or animals outside of research settings. It remains an investigational peptide.
Research Use Only:
The peptide is intended strictly for in vitro testing and laboratory experimentation. It’s not intended for human or animal medical use. It’s not a drug, food, or cosmetic and should not be misbranded, misused, or mislabeled as such.
- - View All Peptides
CJC-1295 with DAC 5mg
Original price was: $49.99.$39.99Current price is: $39.99.Key Research Areas
CJC-1295 with DAC is commonly used in basic and preclinical research settings exploring:
Age-related hormonal decline
GH and IGF-1 dependent signaling pathways
Muscle tissue physiology and regenerative models
Body composition, lipolysis, and metabolic regulation
Synergistic protocols combining GHRH analogs with GHRPs (e.g., GHRP-2, Ipamorelin)
This peptide’s long-acting profile makes it ideal for studies requiring low-frequency dosing protocols and extended endocrine modeling.
Product Features
Peptide Type: Synthetic GHRH analog
Modification: DAC (Drug Affinity Complex) for half-life extension
Research Grade: ≥98% purity (HPLC-verified)
Storage: Store lyophilized at -20°C; reconstituted at 2–8°C
Solubility: Sterile bacteriostatic water or acetic acid (as per protocol)
Disclaimer
This product is provided solely for in vitro and animal model research. It is not intended for human ingestion, injection, therapeutic, or diagnostic use. Use must be carried out under institutional biosafety guidelines and by qualified research personnel. CJC-1295 with DAC is not approved by the FDA, EMA, or any medical authority for clinical use.
